Gradient Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.8M Buy
496,513
+18,509
+4% +$1.49M 0.54% 57
2026
Q1
$41.4M Sell
478,004
-1,129
-0.2% -$108K 0.64% 41
2025
Q4
$46M Buy
479,133
+15,870
+3% +$1.54M 0.73% 36
2025
Q3
$44.1M Buy
463,263
+11,584
+3% +$1.06M 0.74% 37
2025
Q2
$39.4M Buy
451,679
+2,579
+0.6% +$219K 0.72% 40
2025
Q1
$40.4M Buy
449,100
+14,333
+3% +$1.28M 0.81% 36
2024
Q4
$34.7M Buy
434,767
+45,783
+12% +$3.96M 0.7% 41
2024
Q3
$35M Sell
388,984
-13,632
-3% -$1.15M 0.73% 45
2024
Q2
$31.7M Buy
402,616
+15,166
+4% +$1.24M 0.71% 41
2024
Q1
$33.8M Buy
387,450
+2,339
+0.6% +$200K 0.78% 34
2023
Q4
$31.7M Buy
385,111
+64,649
+20% +$4.93M 0.77% 36
2023
Q3
$25.1M Buy
320,462
+7,821
+3% +$655K 0.66% 44
2023
Q2
$27.5M Buy
312,641
+30,925
+11% +$2.66M 0.71% 38
2023
Q1
$22.7M Buy
281,716
+36,777
+15% +$3M 0.62% 43
2022
Q4
$19M Buy
244,939
+44,643
+22% +$3.62M 0.6% 41
2022
Q3
$16.2M Buy
200,296
+26,019
+15% +$2.34M 0.49% 47
2022
Q2
$15.6M Sell
174,277
-3,794
-2% -$384K 0.46% 44
2022
Q1
$19.8M Buy
178,071
+7,596
+4% +$803K 0.51% 44
2021
Q4
$17.6M Buy
170,475
+109,521
+180% +$12.7M 0.45% 48
2021
Q3
$7.64M Buy
60,954
+9,315
+18% +$1.21M 0.21% 127
2021
Q2
$6.41M Buy
51,639
+1,273
+3% +$160K 0.19% 129
2021
Q1
$5.95M Sell
50,366
-77,354
-61% -$9.07M 0.19% 124
2020
Q4
$13.3M Sell
127,720
-1,428
-1% -$157K 0.56% 44
2020
Q3
$13.4M Buy
129,148
+9,231
+8% +$927K 0.56% 44
2020
Q2
$11M Buy
119,917
+3,194
+3% +$306K 0.5% 53
2020
Q1
$10.5M Buy
116,723
+9,987
+9% +$1.06M 0.57% 41
2019
Q4
$12.1M Buy
106,736
+3,418
+3% +$375K 0.54% 45
2019
Q3
$11.2M Sell
103,318
-7,273
-7% -$759K 0.55% 40
2019
Q2
$10.8M Buy
110,591
+20,401
+23% +$1.86M 0.55% 35
2019
Q1
$8.21M Sell
90,190
-12,701
-12% -$1.14M 0.53% 43
2018
Q4
$9.36M Sell
102,891
-6,988
-6% -$653K 0.56% 28
2018
Q3
$10.8M Buy
109,879
+3,547
+3% +$328K 0.55% 27
2018
Q2
$9.1M Buy
106,332
+4,309
+4% +$360K 0.49% 40
2018
Q1
$8.18M Buy
102,023
+10,284
+11% +$848K 0.44% 63
2017
Q4
$7.41M Buy
91,739
+8,274
+10% +$663K 0.43% 66
2017
Q3
$6.49M Buy
83,465
+4,345
+5% +$361K 0.41% 73
2017
Q2
$7.02M Buy
79,120
+4,544
+6% +$383K 0.49% 43
2017
Q1
$6.01M Buy
74,576
+73,891
+10,787% +$5.77M 0.46% 64
2016
Q4
$49K Sell
685
-147
-18% -$11.5K ﹤0.01% 267
2016
Q3
$72K Sell
832
-157
-16% -$13.7K 0.01% 234
2016
Q2
$86K Sell
989
-239
-19% -$19.3K 0.01% 222
2016
Q1
$92K Buy
1,228
+104
+9% +$7.83K 0.01% 215
2015
Q4
$86K Hold
1,124
0.01% 215
2015
Q3
$75K Sell
1,124
-54
-5% -$3.98K 0.01% 207
2015
Q2
$87K Sell
1,178
-246
-17% -$18.8K 0.01% 206
2015
Q1
$111K Buy
1,424
+745
+110% +$56.5K 0.02% 190
2014
Q4
$49K Hold
679
0.01% 235
2014
Q3
$42K Buy
679
+54
+9% +$3.43K 0.01% 227
2014
Q2
$40K Buy
625
+36
+6% +$2.19K 0.01% 234
2014
Q1
$36K Buy
589
+164
+39% +$9.55K 0.01% 225
2013
Q4
$24K Sell
425
-17
-4% -$964 0.01% 284
2013
Q3
$24K Hold
442
0.01% 215
2013
Q2
$23K Buy
+442
New +$21.8K 0.01% 219

Other funds holding MDT

Gradient Investments's MDT Position: Q2 2026 in Review

Gradient Investments increased its Medtronic (MDT) stake by 3.9% in Q2 2026, buying an estimated $1.49M and bringing the position to 496,513 shares worth $38.8M. The position accounts for 0.54% of the portfolio, ranked #57.

Gradient Investments first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $46M in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Gradient Investments held 496,513 shares of Medtronic worth $38.8M as of Q2 2026.
  • Gradient Investments bought 18,509 Medtronic shares in Q2 2026, an estimated $1.49M.
  • Medtronic made up 0.54% of Gradient Investments's portfolio in Q2 2026, its #57 holding.
  • Gradient Investments first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Gradient Investments's Medtronic position peaked at $46M in Q4 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.